Transfusion Reaction
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
DiagastFrance - Loos
3 programsABTEST cardN/A1 trial
ABTest Card®REF and ABTest Card®NEWN/A1 trial
Safety Test ABO and ABTest Card®N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
DiagastSafety Test ABO and ABTest Card®
DiagastABTest Card®REF and ABTest Card®NEW
DiagastABTEST card
Clinical Trials (3)
Total enrollment: 400 patients across 3 trials
Clinical Performance Study of Safety Test ABO Device
Start: Sep 2024Est. completion: Jan 2025100 patients
N/ANot Yet Recruiting
Clinical Performance Study of the ABTest Card® Device.
Start: Sep 2024Est. completion: Jan 2025200 patients
N/ANot Yet Recruiting
ABTEST© Card Clinical Perfomance Study
Start: Jun 2021Est. completion: Nov 2021100 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.